HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

nanoemulsion-Rosmarinus officinalis essential oil

Also Known As:

NEORO

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Oils: 1493
  - Volatile Oils: 3403
    - nanoemulsion-Rosmarinus officinalis essential oil: 2

Experts

1.	Fernandes, Caio Pinho: 2 articles (12/2020 - 02/2018)
2.	Alves Barros, Albenise Santana: 1 article (12/2020)
3.	Barbosa, Robson: 1 article (12/2020)
4.	Cesar Matias Pereira, Arlindo: 1 article (12/2020)
5.	Faria E Souza, Belmira Silva: 1 article (12/2020)
6.	Leticia Elizandra Boettger, Mehl: 1 article (12/2020)
7.	Lobato Duarte, Jonatas: 1 article (12/2020)
8.	Maciel Ferreira, Adriana: 1 article (12/2020)
9.	Maciel Ferreira, Irlon: 1 article (12/2020)
10.	Santos Rodrigues, Ana Paula: 1 article (12/2020)

Related Diseases

1.	Dyslipidemias (Dyslipidemia) 12/01/2020 - "This study aimed to evaluate the effect of Rosmarinus officinalis essential oil (EORO, 100 mg/kg) and its nanoemulsion (NEORO, 500 µg/kg) on Triton and coconut saturated-fat-induced (CSF) dyslipidemias using Wistar rats. " 12/01/2020 - "Overall, in the Triton-induced dyslipidemia model, EORO treatment had superior values than NEORO's (and simvastatin), although the differences were not too high, while in the CSF model, the values were mixed. "
2.	Atherosclerosis 12/01/2020 - "In contrast, the groups treated with EORO, NEORO, and simvastatin had significantly reduced hypercholesterolemia and hypertriglyceridemia, reduced abdominal fat gain, and absence of atherogenesis in the vascular endothelium. "
3.	Hypertriglyceridemia 12/01/2020 - "In contrast, the groups treated with EORO, NEORO, and simvastatin had significantly reduced hypercholesterolemia and hypertriglyceridemia, reduced abdominal fat gain, and absence of atherogenesis in the vascular endothelium. "
4.	Inflammation (Inflammations) 02/01/2018 - "This work paves the way for future investigations related to the therapeutic role of NEORO in the inflammation process."
5.	Hypercholesterolemia 12/01/2020 - "In contrast, the groups treated with EORO, NEORO, and simvastatin had significantly reduced hypercholesterolemia and hypertriglyceridemia, reduced abdominal fat gain, and absence of atherogenesis in the vascular endothelium. "

Related Drugs and Biologics

1.	Rosmarinus officinalis essential oil (EORO)
2.	Simvastatin (Zocor)